📰 Prospera Lung News
Prospera Lung News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Prospera Lung. Real-time updates on events, politics, business and more.
April 8, 2024
Prospective, multi-center Trifecta-Heart and DTRT-2 studies demonstrate excellent performance of the Prospera Heart test for detecting rejection in adults and pediatrics ...
August 16, 2023
The test will be covered under the existing LCD for molecular testing for solid organ transplant rejection in surveillance monitoring.
August 16, 2023
Represents third covered indication for Prospera ... -Today at 09:07 am- MarketScreener
April 7, 2022
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced the publication of the VALID study1, showcasing its...
October 24, 2021
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in transforming care through genetic and cell-free DNA (cfDNA) testing, announced the launch and...
October 22, 2021
Natera, Inc. (NASDAQ: NTRA), a leader in transforming care through genetic and cell-free DNA (cfDNA) testing, announced the launch and availability...
October 19, 2021
AUSTIN, Texas, Oct. 18, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in transforming care through genetic and cell-free DNA (cfDNA) testing, announced the launch and availability of its
October 18, 2021
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in transforming care through genetic and cell-free DNA (cfDNA) testing, announced the launch and...
October 6, 2021
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in improving patient outcomes through genetic and cell-free DNA (cfDNA) testing, announced the completion...
October 6, 2021
AUSTIN, Texas, Oct. 6, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in improving patient outcomes through genetic and cell-free DNA (cfDNA) testing, announced the completion of the VALID